These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30890584)

  • 1. Vogt-Koyanagi-Harada disease.
    Street D; Sivaguru A; Sreekantam S; Mollan SP
    Pract Neurol; 2019 Aug; 19(4):364-367. PubMed ID: 30890584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome].
    González-Delgado M; González C; Blázquez JI; Salas-Puig J; Castro J; Hernández-Lahoz C
    Neurologia; 2004 Sep; 19(7):401-3. PubMed ID: 15273890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
    Su E; Oza VS; Latkany P
    J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
    Manethova K; Ernest J; Hrevus M
    Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
    Perente I; Utine CA; Cakir H; Kaya V; Tutkun IT; Yilmaz OF
    Int Ophthalmol; 2009 Feb; 29(1):33-7. PubMed ID: 17952373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study.
    Ingolotti M; Schlaen BA; Roig Melo-Granados EA; Ruiz García H; Aguilera Partida JA
    Am J Case Rep; 2019 Mar; 20():300-305. PubMed ID: 30842390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute retinal necrosis (ARN) following chickenpox in a patient of Vogt-Koyanagi-Harada (VKH) syndrome using immunosuppressants.
    Gupta R; Tyagi M; Balakrishnan D; Rani PK
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M; Arf Karacorlu S; Ozdemir H
    Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies].
    Hiraki Y; Kuwasaki N; Shoji H; Kaji M; Kuboshiro T
    Rinsho Shinkeigaku; 1989 Jan; 29(1):54-8. PubMed ID: 2663296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
    Bordaberry MF
    Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
    Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
    Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report.
    Khatri S; Khatri S; Regmi S; Pyakurel S; Bhattarai S; Barman P; Manandhar D; Singh AK
    JNMA J Nepal Med Assoc; 2022 Oct; 60(254):902-905. PubMed ID: 36705150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    Li AS; Tang PH; Do DV
    JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.